Who
Anna Berkenblit
Director
Company insider
Files Form 4 as: Director, Surrozen; SVP & Chief Medical Officer, ImmunoGen.
In numbers
- Trades disclosed
- 33
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $523K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 21 Feb 2017
- Last trade
- 13 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 May 2026filed 14 May 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,550 at $0.00 | filing |
| 13 May 2026filed 14 May 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,550 at $0.00 | filing |
| 14 May 2025filed 15 May 2025 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,333 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,333 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | ImmunoGen | SEC FORM 4 Code A | $13K3,264 at $4.05 | filing |
| 18 May 2023filed 22 May 2023 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 3 Feb 2023filed 7 Feb 2023 | ImmunoGenoption or derivative | SEC FORM 4 Code A | —42,700 at $0.00 | filing |
| 3 Feb 2023filed 7 Feb 2023 | ImmunoGenoption or derivative | SEC FORM 4 Code A | —256,300 at $0.00 | filing |
| 3 Feb 2023filed 7 Feb 2023 | ImmunoGenoption or derivative | SEC FORM 4 Code A | —63,400 at $0.00 | filing |
| 30 Dec 2022filed 3 Jan 2023 | ImmunoGen | SEC FORM 4 Code A | $1,709436 at $3.92 | filing |
| 14 Nov 2022filed 27 Dec 2022 | ImmunoGenoption or derivative | SEC FORM 4 Code A | —222,300 at $0.00 | filing |
| 30 Jun 2022filed 5 Jul 2022 | ImmunoGen | SEC FORM 4 Code A | $12K3,073 at $3.83 | filing |
| 7 Jun 2022filed 9 Jun 2022 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 20 May 2022filed 27 Dec 2022 | ImmunoGenoption or derivative | SEC FORM 4 Code A | —111,150 at $0.00 | filing |
| 4 Feb 2022filed 8 Feb 2022 | ImmunoGenoption or derivative | SEC FORM 4 Code A | $1.7M311,700 at $5.32 | filing |
| 31 Dec 2021filed 4 Jan 2022 | ImmunoGen | SEC FORM 4 Code A | $9,8621,761 at $5.60 | filing |
| 30 Jun 2021filed 2 Jul 2021 | ImmunoGen | SEC FORM 4 Code A | $11K2,062 at $5.52 | filing |
| 5 Feb 2021filed 9 Feb 2021 | ImmunoGenoption or derivative | SEC FORM 4 Code A | $2.2M282,019 at $7.69 | filing |
| 31 Dec 2020filed 5 Jan 2021 | ImmunoGen | SEC FORM 4 Code A | $8,9002,203 at $4.04 | filing |
| 30 Jun 2020filed 2 Jul 2020 | ImmunoGen | SEC FORM 4 Code A | $12K3,047 at $3.91 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.